Icecure Medical Ltd (NASDAQ: ICCM) kicked off on Monday, up 4.81% from the previous trading day, before settling in for the closing price of $0.81. Over the past 52 weeks, ICCM has traded in a range of $0.48-$1.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 33.95% over the past five years. While this was happening, its average annual earnings per share was recorded 13.54%. With a float of $24.12 million, this company’s outstanding shares have now reached $45.73 million.
Let’s look at the performance matrix of the company that is accounted for 77 employees. In terms of profitability, gross margin is 40.37%, operating margin of -429.36%, and the pretax margin is -407.16%.
Icecure Medical Ltd (ICCM) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Icecure Medical Ltd is 51.28%, while institutional ownership is 0.73%.
Icecure Medical Ltd (ICCM) Latest Financial update
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.09 earnings per share (EPS), higher than consensus estimate (set at -0.09) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.54% per share during the next fiscal year.
Icecure Medical Ltd (NASDAQ: ICCM) Trading Performance Indicators
Take a look at Icecure Medical Ltd’s (ICCM) current performance indicators. Last quarter, stock had a quick ratio of 2.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Icecure Medical Ltd (ICCM)
Icecure Medical Ltd (NASDAQ: ICCM) saw its 5-day average volume 1.22 million, a positive change from its year-to-date volume of 0.53 million. As of the previous 9 days, the stock’s Stochastic %D was 80.22%. Additionally, its Average True Range was 0.07.
During the past 100 days, Icecure Medical Ltd’s (ICCM) raw stochastic average was set at 88.10%, which indicates a significant increase from 87.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 100.17% in the past 14 days, which was higher than the 70.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6324, while its 200-day Moving Average is $0.9427. Nevertheless, the first resistance level for the watch stands at $0.8899 in the near term. At $0.9299, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9898. If the price goes on to break the first support level at $0.7900, it is likely to go to the next support level at $0.7301. The third support level lies at $0.6901 if the price breaches the second support level.
Icecure Medical Ltd (NASDAQ: ICCM) Key Stats
The company with the Market Capitalisation of 41.63 million has total of 45,623K Shares Outstanding. Its annual sales at the moment are 3,230 K in contrast with the sum of -14,650 K annual income. Company’s last quarter sales were recorded 1,010 K and last quarter income was -3,080 K.
